A radioligand test to detect inhibitors of endothelin-1 binding to its receptors in bovine atrial and porcine cerebral membranes wasused to screen fungal metabolites from stationary fermentations. Inhibitory activity, observed in culture extracts of twoAcremonium species, led to the discovery of aselacins A, B and C. Aselacin A inhibits binding to both membranefractions with IC5Osof approximately 20 /ig/ml.
transported on ice from the abattoir. Atrial tissue was dissected free and homogenized in buffer A in a Waring blender. Buffer A consisted of 5mMTris, l mMMgCl2, 250mMsucrose, 0.5mg/ml phosphoramidon and 0.5mg/ml leupeptin at pH 7.4. The homogenate was centrifuged at 3,000 xg for 15 minutes at 4°C to pellet the debris. The supernatant, containing the plasma membrane fraction, was centrifuged at 72,000 xg for 30 minutes. The pellet was washed twice in buffer B, which consisted of 75mMTris, 25mMMgCl2, 0.5mg/ml phosphoramidon and 0.5mg/ml leupeptin at pH 7.4. The washed pellet was resuspended at 1 g tissue per ml in buffer B containing 250mMsucrose. Aliquots were frozen immediately at -20°C. The non-specific binding of [125I]endothelin-l to crude bovine atrial membranes is14+1%.
ET-1 receptors of ETBsubtype were prepared from porcine brain membranes. Porcine brains were transported on ice from the abattoir. Cerebral tissue was dissected free and homogenized with a Virtis Tempest Virtishear in buffer A. The homogenate was centrifuged at 3,000 x g for 15 minutes at 4°C to pellet the debris. The supernatant, containing the plasma membrane fraction, was centrifuged at 72,000 x g for 30 minutes at 4°C. The pellet was washed twice in buffer B. The washed pellet was resuspended at 1 g of tissue per ml in buffer B containing 250mMsucrose. Aliquots were frozen immediately. The non-specific binding of crude porcine cerebral membranes is 15 + 1 %.
Fungal cultures for the screen were grown for 21 days in solid state fermentations (30ml medium plus 25 g Spoon Size Shredded Wheat in a 500-ml Erlenmeyer flask). At harvest, 25ml of acetone was added to the flask. Six hours later, 30ml of toluene-ethyl acetate 1 : 1 mixture was added and the flasks were placed at 4°C for 20 hours. Twenty-five ml of the extract was removedand the solvent evaporated. The residue was used for the radioligand assays. To assess the ability of extracts to block [125I]ET-1 binding, an aliquot of atrial or cerebral membrane preparation was thawed and diluted 1 to 20 in binding buffer, which consisted of 50mMTris, pH 7.4, 25mMMgCl2, l mMEDTA, 0.5mg/ml phosphoramidon, 0.5mg/ml leupeptin, 0.1% CHAPS and 0.5% bovine serum albumin. Fermentation extract samples for testing were dissolved in 95%ethanol at a 50-fold concentration of the first extraction. Five /zl was transferred to wells of a 96-well microtiter tray. The ethanol was removed under vacuumand 100/zl diluted membranewas added for a two hour pre-incubation period. A 100/il aliquot of a solution of [125I]ET-1 (20,000dpm, Amersham) in binding buffer was added to each well. The trays were incubated for an additional two hours. Membranes were collected on glass fiber filters (Packard self-aligning RG filters) with a 96-well harvester (Inotech Biosystems). The filters were washed twice with binding buffer, removed from the harvester and dried in a vacuumoven. The radioactivity associated with the membranes was determined with a Packard Matrix 9600^-detector. Non-specific binding was defined as the radioactivity associated with membranes in the presence of 50 ng/ml of unlabeled ET-1 (Peninsula Laboratories, Belmont, U.S.A.).
Microorganisms
The producing microorganisms were isolated from soil samples collected in Asela, Ethiopia and at Cape Canaveral, U.S.A. Both cultures were morphologically recognized by light microscopy as Acremonium and were described by criteria suggested by Onions and for 45 minutes at 121°C. The medium used to produce aselacins A and B consisted of dextrin 1.6%, glucose monohydrate 0.8%, dried distillers solubles (Brown, Foreman Distillers, Louisville, U.S.A.) 0.4%, primary whole yeast 0.4% and CaCO30.16%. The pH was adjusted to 7.0 with NaOH. The medium for the production of aselacin C consisted of starch 2.4%, molasses 1.6%, spray-dried lard water (Inland Molasses Co., Dubuque, U.S.A.) 0.8%, primary whole yeast 0.4% and CaCO3 0.16%. The pH was adjusted to 7.0. Media were dispensed at 1,440 ml into 2-liter Erlenmeyer flasks and sterilized for 45 minutes at 121°C. The inoculation process consisted of mixing vegetative seed growth at 5% with the liquid medium. The mixture was poured onto and mixed with the Shredded Wheat, which had been pre-sterilized in the carboys. Incubation of the carboys was at 20°C for 21 days.
Biological Activity
The concentration of the isolated compounds, aselacins A and C, which inhibited 50% of the binding activity of ET-1 (IC50) to each of the receptor membranes, was determined in the assay described for Incubation conditions: 7 days at 22°C.
Growth was on corn meal agar with incubation for 1 week at 25°C. Growthwas on corn meal agar with incubation for 1 weekat 25°C. smooth, colorless and elliptical. They typically measure 3~4Jum x 3.5~5 fim and are produced singly, in long false chains and occasionally in loose heads. However, the two strains differ in gross colony morphology and color. These cultural differences, appearing on malt extract agar and on potato flakes agar15), are summarized in Table 1 . The microscopic morphology indicated that these strains are closely related hyphomycetous fungi belonging to the genus Acremonium. Scanning electron micrographs show the Acremonium-likG morphology of strain AB2093T-194 (Figs. 1 and 2) . Fermentation
The solid state fermentations were not monitored during incubation. Aselacin production was improved by decreasing the amount of mediumand Shredded Wheat in the carboys, presumably improving aeration. It was possible to detect aselacins in liquid, agitated fermentations but attempts to optimize yields in fermenters have not been undertaken. Biological Activity The inhibition of binding results for aselacin A and C are shown in Fig. 3 . The IC50 of aselacin A with atrial membranes was determined to be 22 /xg/ml and 20 /ig/ml with cerebral membranes. The IC50 of aselacin C was 60 //g/ml against atrial membranes and 80 fig/ml with cerebral membranes. There was no selectivity from aselacins A and C for receptor membranesof ETAor ETBsubtypes. Insufficient quantity of aselacin B was isolated for IC50 determination, however, the compound was demonstrated to inhibit VOL.47 NO. 5 THE JOURNAL OF ANTIBIOTICS binding during the activity-driven isolation process. 527 
Conclusions
A radioligand assay was successfully used to identify fermentation extracts that inhibited binding of [125I]ET-1 to its receptors. Purification, followed by the bioassay, led to the isolation of aselacins A, B and C. Aselacin A inhibits binding to receptors in both atrial and cerebral membranes with IC5Os of approximately 20 /xg/ml. Stationary fermentations appear to be an excellent source of interesting fungal metabolites.
